The accelerated approval of oncologic drugs lessons from ponatinib

Vinay Prasad; Sham Mailankody

doi:10.1001/jama.2013.284531

The accelerated approval of oncologic drugs lessons from ponatinib

Vinay Prasad, Sham Mailankody

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	353-354
Number of pages	2
Journal	JAMA
Volume	311
Issue number	4
DOIs	https://doi.org/10.1001/jama.2013.284531
State	Published - Jan 22 2014
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.2013.284531

Cite this

@article{dccc4c4fd9734094959de3a406895809,

title = "The accelerated approval of oncologic drugs lessons from ponatinib",

author = "Vinay Prasad and Sham Mailankody",

year = "2014",

month = jan,

day = "22",

doi = "10.1001/jama.2013.284531",

language = "English (US)",

volume = "311",

pages = "353--354",

journal = "JAMA - Journal of the American Medical Association",

issn = "0002-9955",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - The accelerated approval of oncologic drugs lessons from ponatinib

AU - Prasad, Vinay

AU - Mailankody, Sham

PY - 2014/1/22

Y1 - 2014/1/22

UR - http://www.scopus.com/inward/record.url?scp=84892701195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892701195&partnerID=8YFLogxK

U2 - 10.1001/jama.2013.284531

DO - 10.1001/jama.2013.284531

M3 - Comment/debate

C2 - 24449310

AN - SCOPUS:84892701195

SN - 0002-9955

VL - 311

SP - 353

EP - 354

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 4

ER -

The accelerated approval of oncologic drugs lessons from ponatinib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this